All Stories

  1. Force Spectroscopy by Atomic Force Microscopy as Indicator for Cellular Microplastic Uptake
  2. Combinations of Drugs for Pulmonary Inhalation: A Review of Novel Technologies and Toxicological Evaluation Using Cellular Models
  3. Thyreoglobulin
  4. Hype vs. Health: How Approved Nanomedicines Have Met (or Missed) Early Predictions
  5. Thyreoglobulin
  6. The Effects of Obesity on Lung Physiology, the Prevalence and Severity of Chronic Pulmonary Diseases, and Inhalation Treatment
  7. Development of Co-Amorphous Systems for Inhalation Therapy—Part 2: In Silico Guided Co-Amorphous Rifampicin–Moxifloxacin and –Ethambutol Formulations
  8. Better GRAS than sorry: Excipient toxicity in pulmonary formulations
  9. Development of Co-Amorphous Systems for Inhalation Therapy—Part 1: From Model Prediction to Clinical Success
  10. Immune Modulation with Nanodiscs: Surface Charge Dictates Cellular Interactions and Activation of Macrophages and Dendritic-like Cells
  11. Skin Sensitization Potential of Sensitizers in the Presence of Metal Oxide Nanoparticles In Vitro
  12. Personalization of lipid-based oral dosage forms via filament-based 3D-printing
  13. Archaeosomes for Oral Drug Delivery: From Continuous Microfluidics Production to Powdered Formulations
  14. Animals in Respiratory Research
  15. Pars Distalis and Pars Tuberalis Thyroid-Stimulating Hormones and Their Roles in Macro-Thyroid-Stimulating Hormone Formation
  16. Lipid Nanoparticles as a Shuttle for Anti-Adipogenic miRNAs to Human Adipocytes
  17. Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung
  18. The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening
  19. Assessment of Carbon Nanotubes on Barrier Function, Ciliary Beating Frequency and Cytokine Release in In Vitro Models of the Respiratory Tract
  20. Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease
  21. Non-Cellular Layers of the Respiratory Tract: Protection against Pathogens and Target for Drug Delivery
  22. Replacement Strategies for Animal Studies in Inhalation Testing
  23. Acute Respiratory Distress Syndrome: Focus on Viral Origin and Role of Pulmonary Lymphatics
  24. Initial Biological Assessment of Upconversion Nanohybrids
  25. “Biology and Medicine”: A Section of Nanomaterials Addressing Interactions of Nanomaterials with All Forms of Life
  26. Nanoparticles: Promising Auxiliary Agents for Diagnosis and Therapy of Thyroid Cancers
  27. Replacement Strategies for Animal Studies in Inhalation Testing
  28. Cytokine-Mediated Inflammation in the Oral Cavity and Its Effect on Lipid Nanocarriers
  29. Screening for Effects of Inhaled Nanoparticles in Cell Culture Models for Prolonged Exposure
  30. On Absorption Modeling and Food Effect Prediction of Rivaroxaban, a BCS II Drug Orally Administered as an Immediate-Release Tablet
  31. Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation
  32. Different Sensitivity of Macrophages to Phospholipidosis Induction by Amphiphilic Cationic Drugs
  33. Issues with Cancer Spheroid Models in Therapeutic Drug Screening
  34. Understanding and Preventing Adverse Effects of Tacrolimus Metabolization in Transplant Patients
  35. Impact of drug particle shape on permeability and cellular uptake in the lung
  36. Functional dextran amino acid ester particles derived from N-protected S-trityl-L-cysteine
  37. Cytotoxicity screening of emulsifiers for pulmonary application of lipid nanoparticles
  38. Biological Obstacles for Identifying In Vitro-In Vivo Correlations of Orally Inhaled Formulations
  39. Delivery of Dry Powders to the Lungs: Influence of Particle Attributes from a Biological and Technological Point of View
  40. An automatable platform for genotoxicity testing of nanomaterials based on the fluorometric γ-H2AX assay reveals no genotoxicity of properly surface-shielded cadmium-based quantum dots
  41. Comparison of conventional and advanced in vitro models in the toxicity testing of nanoparticles
  42. The Development of Indicator Cotton Swabs for the Detection of pH in Wounds
  43. Amphiphilic coatings for the protection of upconverting nanoparticles against dissolution in aqueous media
  44. An in vitro and in silico study of the impact of engineered surface modifications on drug detachment from model carriers
  45. Cellular elimination of nanoparticles
  46. Oral uptake of nanoparticles: human relevance and the role of in vitro systems
  47. Cytotoxicity of Nanoparticles Contained in Food on Intestinal Cells and the Gut Microbiota
  48. MECHANISMS IN ENDOCRINOLOGY: Impact of isolated TSH levels in and out of normal range on different tissues
  49. Permeation of Therapeutic Drugs in Different Formulations across the Airway Epithelium In Vitro
  50. In Vitro Assessment of Chronic Nanoparticle Effects on Respiratory Cells
  51. Atomic force microscopy as analytical tool to study physico-mechanical properties of intestinal cells
  52. Intracellular calcium levels as screening tool for nanoparticle toxicity
  53. Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
  54. Interactions between nano-TiO2 and the oral cavity: Impact of nanomaterial surface hydrophilicity/hydrophobicity
  55. Chemotherapy and Chemoprevention by Thiazolidinediones
  56. Analogies in the Adverse Immune Effects of Wear Particles, Environmental Particles, and Medicinal Nanoparticles
  57. Use of whole genome expression analysis in the toxicity screening of nanoparticles
  58. The current role of targeted therapies to induce radioiodine uptake in thyroid cancer
  59. The buccal mucosa as a route for TiO2nanoparticle uptake
  60. Photohardening of polymorphic light eruption patients decreases baseline epidermalLangerhans cell density while increasing mast cell numbers in the papillary dermis
  61. Toxicological Assessment of Inhaled Nanoparticles: Role of in Vivo, ex Vivo, in Vitro, and in Silico Studies
  62. Development of an Advanced Intestinal in Vitro Triple Culture Permeability Model To Study Transport of Nanoparticles
  63. Reaction of monocytes to polystyrene and silica nanoparticles in short-term and long-term exposures
  64. Mucus as Barrier for Drug Delivery by Nanoparticles
  65. Mucus as Physiological Barrier to Intracellular Delivery
  66. Gas Permeation, Mechanical Behavior and Cytocompatibility of Ultrathin Pure and Doped Diamond-Like Carbon and Silicon Oxide Films
  67. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats
  68. Nano-sized and micro-sized polystyrene particles affect phagocyte function
  69. Cellular Targets and Mechanisms in the Cytotoxic Action of Non-biodegradable Engineered Nanoparticles
  70. Titanium dioxide nanoparticles and the oral uptake-route
  71. In Vitro and In Vivo Techniques to Assess Neurotoxicity of Nanoparticles
  72. The oral cavity as a biological barrier system: Design of an advanced buccal in vitro permeability model
  73. Assessment of Long-Term Effects of Nanoparticles in a Microcarrier Cell Culture System
  74. Comparison of two in vitro systems to assess cellular effects of nanoparticles-containing aerosols
  75. Suitability of Cell-Based Label-Free Detection for Cytotoxicity Screening of Carbon Nanotubes
  76. New Diagnostic and Therapeutic Tools for Thyroid Cancer
  77. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
  78. In‐Vitro Permeability of Neutral Polystyrene Particles via Buccal Mucosa
  79. Combination of small size and carboxyl functionalisation causes cytotoxicity of short carbon nanotubes
  80. Nanoparticles in Biology and Medicine: Methods and Protocols. Edited by Mikhail Soloviev.
  81. Interspecies differences in membrane-associated protease activities of thyrocytes and their relevance for thyroid cancer studies
  82. Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties
  83. Differentiation Therapy in Thyroid Carcinoma
  84. Models for oral uptake of nanoparticles in consumer products
  85. Action of polystyrene nanoparticles of different sizes on lysosomal function and integrity
  86. Do antidiabetic medications play a specific role in differentiated thyroid cancer compared to other cancer types?
  87. Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions
  88. Cytotoxity of nanoparticles is influenced by size, proliferation and embryonic origin of the cells used for testing
  89. Evaluation of a physiologicalin vitrosystem to study the transport of nanoparticles through the buccal mucosa
  90. Fibulin-5 mutations link inherited neuropathies, age-related macular degeneration and hyperelastic skin
  91. Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation
  92. Decrease in Dipeptidyl Peptidase IV Activity is Linked to the Efficacy of Differentiating Compounds in Follicular Thyroid Carcinoma Cell Lines
  93. EP4 receptor stimulation down-regulates human eosinophil function
  94. Targeted High-Throughput Sequencing Identifies Mutations in atlastin-1 as a Cause of Hereditary Sensory Neuropathy Type I
  95. Cholesteryl ester hydrolase activity is abolished in HSL macrophages but unchanged in macrophages lacking KIAA1363
  96. Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target
  97. Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticles
  98. Efficient Phagocytosis Requires Triacylglycerol Hydrolysis by Adipose Triglyceride Lipase
  99. Proliferation analysis of the growth plate after diaphyseal midshaft fracture by 5′-bromo-2′-deoxy-uridine
  100. The Neuron: The Basis for Processing and Propagation of Information in The Nervous System
  101. Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation
  102. Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes
  103. Chitosan-4-mercaptobenzoic acid: synthesis and characterization of a novel thiolated chitosan
  104. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C
  105. Chitosan-graft-6-mercaptonicotinic Acid: Synthesis, Characterization, and Biocompatibility
  106. Postpolymerization modification of poly(pentafluorophenyl methacrylate): Synthesis of a diverse water‐soluble polymer library
  107. Efficiency of various dissociation methods for the preparation of thyroid single cell suspensions
  108. The role of nanoparticle size in hemocompatibility
  109. Dipeptidyl peptidase II is not a marker for progression in melanoma
  110. Cytotoxicity of nanoparticles independent from oxidative stress
  111. Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines
  112. Chondrocyte apoptosis enhanced at the growth plate: a physeal response to a diaphyseal fracture
  113. Antitumor Effects of Arsenic Trioxide in Transformed Human Thyroid Cells
  114. Hemocompatibility of various nanoparticles in human blood
  115. Is transketolase like 1 a target for the treatment of differentiated thyroid carcinoma? A study on thyroid cancer cell lines
  116. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas
  117. Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture
  118. Retinol has specific effects on binding of thyrotrophin to cultured porcine thyrocytes
  119. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L
  120. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L
  121. Proteases in malignant tumors
  122. Regional differences and post-mortem stability of enzymatic activities in the retinal pigment epithelium
  123. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma
  124. Mammalian Bax triggers apoptotic changes in yeast
  125. Development of multibank rod retinae in deep-sea fishes
  126. Rod Outer Segment Renewal in the Retinae of Deep-sea Fish
  127. Basal lamina formation by porcine thyroid cells grown in collagen- and laminin-deficient medium
  128. Basal lamina formation by porcine thyroid cells grown in collagen- and laminin-deficient medium
  129. Patterns of rod proliferation in deep-sea fish retinae
  130. The occurrence of dopaminergic interplexiform cells correlates with the presence of cones in the retinae of fish
  131. Mammalian Müller (glial) cells express functional D2 dopamine receptors